前沿研究怎么说?
阿奇霉素治疗重度哮喘的作用机制
阿奇霉素治疗期间注意事项
[1]中国医药教育协会慢性气道疾病专业委员会,中国哮喘联盟.重度哮喘诊断与处理中国专家共识(2024)[J].中华医学杂志, 2024, 104(20): 1759-1789.
[2]Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2024.
[3]Ghimire J J,Jat K R,Sankar J.et al. Azithromycinfor Poorly Controlled Asthma in Children: A Randomized Controlled Trial. Chest 2022 161:6 (1456-1464)
[4]Gibson P G , Yang I A , Upham J W ,et al.Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial[J].Lancet, 2017, 390(10095).
[5]Thomas D, McDonald VM, Stevens S, et al. Effect of Azithromycin on Asthma Remission in Adults With Persistent Uncontrolled Asthma: A Secondary Analysis of a Randomized, Double-Anonymized, Placebo-Controlled Trial. Chest. 2024;166(2):262-270.
[6]Kumar A,Zaidi S,Fay N.et al. Efficacy ofazithromycin in a real worldsevere asthma cohort. European Respiratory Journal 2021 58:SUPPL 65
[7]Niessen NM, Gibson PG, Baines KJ, Barker D, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Jenkins C, Peters MJ, Marks GB, Baraket M, Simpson JL, Fricker M. Sputum TNF markers are increased in neutrophilic and severe asthma and are reduced by azithromycin treatment. Allergy. 2021 Jul;76(7):2090-2101.
[8]Nguyen T H,Eyers F,Yang M.et al. Azithromycinmodulates viral-induced asthma exacerbation by targeting the innate immune response. European Respiratory Journal 2019 54 Supplement 63
[9]Shukla SD,Taylor SL,Gibson PG,et al. Add-onazithromycin reduces sputum cytokines in non-eosinophilic asthma: An AMAZES substudy. Thorax 2021 76:7 (733-736)
[10]Jabeen M F,Lason W, Mahdi M,et al.Single cell analysis reveals mechanisms of azithromycin and regulation of mucosal immunity in severe asthma. Thorax2023 78 (A2-A3)
[11]Ponnuswamy A,Ajay H,Gordon T.et al. Real-world study on the use of azithromycin in asthma:experience from a district teaching hospital. Chest2021 160:4 (A52)
[12]Lopes Dos Santos Santiago G,Brusselle G. et al.Influence of chronicazithromycin treatment on the composition of the oropharyngeal microbial community in patients with severe asthma. BMC Microbiology 2017 17:1 Article Number 109